carnevalemanfredonia.it
» » Corticobasal Ganglionic Degeneration: Cognitive And Functional Aspects

eBook Corticobasal Ganglionic Degeneration: Cognitive And Functional Aspects download

by Rita Moretti,Paola Torre,Rodolfo M. Antonello

eBook Corticobasal Ganglionic Degeneration: Cognitive And Functional Aspects download ISBN: 1594543887
Author: Rita Moretti,Paola Torre,Rodolfo M. Antonello
Publisher: Nova Science Pub Inc; UK ed. edition (May 18, 2005)
Language: English
Pages: 143
ePub: 1333 kb
Fb2: 1520 kb
Rating: 4.1
Other formats: txt mbr docx azw
Category: Medics
Subcategory: Medicine

Moretti R. Corticobasal ganglionic degeneration, cognitive and functional aspects.

Moretti R. Nova Science Pub Inc. (2005) ISBN:1594543887. 4. Tiwari D, Amar K. A case of corticobasal degeneration presenting with alien limb syndrome.

Corticobasal Ganglionic Degeneration book. Start by marking Corticobasal Ganglionic Degeneration: Cognitive And Functional Aspects as Want to Read: Want to Read savin. ant to Read.

Progressive supranuclear palsy and corticobasal ganglionic degeneration: Differentiation by clinical features and neuroimaging techniques.

Cortico-basal ganglionic degeneration is a rare degenerative pathology that involves parietal areas and gradually determines frontal involvement. The aim of our work was to describe the main radio-logical findings in this pathology and to evaluate the cortical activation in these patients by f-MRI during simple and complex movements. Patients and methods. Progressive supranuclear palsy and corticobasal ganglionic degeneration: Differentiation by clinical features and neuroimaging techniques.

Authors: Rita Moretti Paola Torre Rodolfo M Antonello Marta Vidus Rosin Francesca Esposito Matej Rubelli Furman Giuseppe Bellini. The on-freezing phenomenon: cognitive and behavioral aspects. Am J Alzheimers Dis Other Demen 2012 May;27(3):196-201. Medicina Clinica, Ambulatorio Complicanze Internistiche Cerebrali, Dipartimento Universitario Clinici di scienze Mediche Tecnologiche e Traslazionali, Università degli Studi di Trieste, Italy. Authors: Rita Moretti Paola Torre Rodolfo M Antonello Francesca Esposito Giuseppe Bellini. Parkinsons Dis 2011 14;2011:746303.

The clinical syndrome of asymmetric parkinsonism associated with cortical abnormalities along with peculiar pathology come to be known as corticobasal ganglionic degeneration (CBGD), actually defined simply as corticobasal degeneration (CBD). The definition of the clinical syndrome of CBD is still evolving. Ideally, the complete and accurate characterisation of the clinical syndrome is contingent on diagnosing all subjects who have the disease and excluding subjects who do not.

Rita Moretti, Paola La Torre, Rodolpho M Antonello, Giuseppe MD. .We studied seven patients with corticobasal degeneration (CBD) from a clinical and imaging perspective.

Rita Moretti, Paola La Torre, Rodolpho M Antonello, Giuseppe MD Cazzato, A. Cazzato G. Bava. Corticobasal degeneration: structural and functional MRI and single-photon emission computed tomography. Maja Ukmar, Rita Moretti, Paola García-dela Torre, Rodolpho M Antonello, Renata Longo, Amarjeet Kaur Bava. We describe the main morphological features of CBD and, using functional MRI, try to define th. More).

Rita Moretti, Paola Torre Rodolfo M. Antonello Maja . Corticobasal degeneration: neuropathologic and clinical heterogeneity. Cortical-basal ganglionic degeneration: a clinical, functional and cognitive evaluation (1-year follow-up). J Neurol Sci 2000;182:29-35 29. Antonello Maja Ukmar Renata Longo Giuseppe Cazzato Antonio Bava. Department of Physiology and Pathology Department of Internal Medicine and Clinical Neurology Institute of Radiology Institute of Physics, University of Trieste, Italy. Neurology 1997;48:959-969 11. Leiguarda R, Lees A, Morello M, Marsden C. The nature of apraxia in corticobasal degeneration.

Corticobasal degeneration (CBD) is a rare, neurodegenerative disease involving the cerebral cortex and the basal ganglia

Corticobasal degeneration (CBD) is a rare, neurodegenerative disease involving the cerebral cortex and the basal ganglia. CBD symptoms typically begin in people from 50 to 70 years of age, and the average disease duration is six years.

Complex distal movement in cortical-basal ganglionic degeneration. Previous Document: Molecular aspects of neurodegeneration in Alzheimer's disease. A functional evaluation. MedLine Citation: PMID: 12224793 Owner: NLM Status: MEDLINE. Rita Moretti; Paola Torre; Rodolfo M Antonello; Maja Ukmar; Renata Longo; Giuseppe Cazzato; Antonio Bava. Related Documents : 18483723 - Interval timing and trajectory in unequal amplitude movements. Next Document: Normal sympathetic nervous system response in reflex sympathetic dystrophy.

Depression in vascular pathologies: the neurologist's point of view Rita Moretti, Elena Bernobich, Francesca Esposito, Paola Torre, Rodolfo M Antonello, Luisa De Angelis, Giuseppe BelliniMedicina. Jul 2011 Vascular Health and Risk Management, Rita Moretti, Elena Bernobich, Francesca Esposito, et al. Medication-overuse headache: citalopram associated with analgesics withdrawal as possible treatment. Dec 2003 The Journal of Headache and Pain, Rita Moretti, Paola Torre, Antonio Bava, et al. Headache.

The clinical syndrome of asymmetric parkinsonism associated with cortical abnormalities along with peculiar pathology has come to be known as corticobasal ganglionic degeneration (CBGD), actually defined simply as corticobasal degeneration (CBD). The definition of the clinical syndrome of CBD is still evolving. Ideally, the complete and accurate characterisation of the clinical syndrome is contingent on diagnosing all subjects who have the disease and excluding subjects who do not. The apparent rarity of the disease makes it a formidable task to accumulate a sufficient number of cases to analyse and obtain meaningful results, as well as making it difficult for physicians to gain familiarity with and to recognise the syndrome. The aim of this work will be to determine the nature of CBD, its clinical impact and its cortical involvement, by evaluating functional imaging and cognitive neuropsychological evaluation.